2018 updated European League Against Rheumatism evidence-based recommendations for the diagnosis of gout

Autor: T.L.Th.A. Jansen, Leonardo Punzi, Jakub Zavada, Florence Tubach, Anne-Kathrin Tausche, Malcolm Coyfish, Hein J.E.M. Janssens, J. Pimentao, Thomas Bardin, Till Uhlig, Pascal Richette, S Guillo, Christian D Mallen, Alexander So, Fabio Becce, Weiya Zhang, Fernando Perez-Ruiz, Eliseo Pascual, Anthony Pywell, George Nuki, Johann Castaneda, Michael Doherty, V. Barskova, Frédéric Lioté

Publikováno v: ANNALS OF THE RHEUMATIC DISEASES
r-ISABIAL. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica y Sanitaria de Alicante
instname
Annals of the Rheumatic Diseases, 79, 31-38
Annals of the Rheumatic Diseases, 79, 1, pp. 31-38

Contains fulltext : 225037.pdf (Publisher’s version ) (Closed access) Although gout is the most common inflammatory arthritis, it is still frequently misdiagnosed. New data on imaging and clinical diagnosis have become available since the first EUL

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f286a344bb0917a0f356545b09f97b1e
https://doi.org/10.1136/annrheumdis-2019-215315

Crystal-proven gout patients have an increased mortality due to cardiovascular diseases, cancer, and infectious diseases especially when having tophi and/or high serum uric acid levels: a prospective cohort study

Autor: Jaap Fransen, Gerard A. Rongen, T.L.Th.A. Jansen, Matthijs Janssen, Iris J.M. Disveld, Hein J.E.M. Janssens, Sahel Zoakman, Laura B.E. Kienhorst

Publikováno v: Clinical Rheumatology, 38, 5, pp. 1385-1391
Clinical Rheumatology, 38, 1385-1391

To investigate the cause-specific mortality and the possible involved clinical characteristics with increased mortality in a cohort of 700 patients with crystal-proven gout. The cause-specific mortality of gout was compared to the mortality of the ge

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::907ed619a556992ca5541fbe3f3661f2
https://hdl.handle.net/2066/203863

Crystal-proven Gout and Characteristic Gout Severity Factors Are Associated with Cardiovascular Disease

Autor: Sahel Zoakman, Hein J.E.M. Janssens, Jaap Fransen, Matthijs Janssen, Iris J.M. Disveld, Gerard A. Rongen, Laura B.E. Kienhorst

Publikováno v: The Journal of Rheumatology, 45, 6, pp. 858-863
The Journal of Rheumatology, 45, 858-863

Objective.Our aim was to examine the prevalence of cardiovascular disease (CVD) in patients with crystal-proven gout compared to arthritis controls. Further, we analyzed the association between characteristic gout severity factors and CVD to provide

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a1afe70733fa109c469070833b1e4a7e
https://pubmed.ncbi.nlm.nih.gov/29657151

THU0428 On the incidence of gout flares in primary care: a retrospective cohort study

Autor: M. Flendrie, Michael Janssen, Jaap Fransen, Hein J.E.M. Janssens

Publikováno v: Poster Presentations.

Background From rheumatologist point of view (secondary care) there is a serious concern about suboptimal treatment of gout patients in primary care with warnings for worse prognostic consequences.(1) Some refer even to a “state of suboptimal gout

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::b634346c222afef946788c0203512169
https://doi.org/10.1136/annrheumdis-2017-eular.6295

2016 updated EULAR evidence-based recommendations for the management of gout

Autor: Fabio Becce, Frédéric Lioté, Jakub Zavada, George Nuki, Johann Castañeda-Sanabria, Florence Tubach, Leonardo Punzi, Weiya Zhang, Michael Doherty, V. Barskova, M. Coyfish, S Guillo, T.L.Th.A. Jansen, Thomas Bardin, Till Uhlig, Hein J.E.M. Janssens, J. Pimentao, Pascal Richette, Eliseo Pascual, Alexander So, Anne-Kathrin Tausche, T Pywell, Fernando Perez-Ruiz, Christian D Mallen

Publikováno v: Annals of the Rheumatic Diseases, 76, 1, pp. 29-42
ANNALS OF THE RHEUMATIC DISEASES
r-ISABIAL. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica y Sanitaria de Alicante
instname
r-FISABIO: Repositorio Institucional de Producción Científica
Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana (FISABIO)
Annals of the Rheumatic Diseases, 76, 29-42
r-FISABIO. Repositorio Institucional de Producción Científica

BackgroundNew drugs and new evidence concerning the use of established treatments have become available since the publication of the first European League Against Rheumatism (EULAR) recommendations for the management of gout, in 2006. This situation

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bdd236e518740ec11d8b2b12a865711a
https://hdl.handle.net/2066/180806